Patriot Financial Group Insurance Agency’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MIH
MSR
PR
SO
WT
Patriot Financial Group Insurance Agency's XBI Position: Q2 2026 in Review
Patriot Financial Group Insurance Agency reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 50% in Q2 2026, selling an estimated $1.1M and leaving 8,162 shares worth $1.29M. The position accounts for 0.13% of the portfolio, ranked #182.
Patriot Financial Group Insurance Agency first reported a position in XBI in Q2 2017 and has held it in 18 quarters since. The position peaked at $2.08M in Q1 2026. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Patriot Financial Group Insurance Agency held 8,162 shares of State Street SPDR S&P Biotech ETF worth $1.29M as of Q2 2026.
- Patriot Financial Group Insurance Agency sold 8,160 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.1M.
- State Street SPDR S&P Biotech ETF made up 0.13% of Patriot Financial Group Insurance Agency's portfolio in Q2 2026, its #182 holding.
- Patriot Financial Group Insurance Agency first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and has held it in 18 quarters since.
- Patriot Financial Group Insurance Agency's State Street SPDR S&P Biotech ETF position peaked at $2.08M in Q1 2026.
- 551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Patriot Financial Group Insurance Agency's 13F filing for Q2 2026, filed 16 Jul 2026.